A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia

Arthritis and Rheumatism

Volumn 40, Issue 9, 1997, Pages 1560-1570

  Wolfe, Frederick ^a,b   Anderson, Janice ^b   Harkness, Deborah ^b   Bennett, Robert M ^c   Caro, Xavier J ^d   Goldenberg, Don L ^e   Russell, I Jon ^f   Yunus, Muhammad B ^g  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b ARTHRITIS RESEARCH CENTER FOUNDATION   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TUFTS UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; COMORBIDITY; DISEASE SEVERITY; EMOTIONAL STRESS; FEMALE; FIBROMYALGIA; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; WORK DISABILITY;

ADULT; AGED; DEMOGRAPHY; DRUG UTILIZATION; FEMALE; FIBROMYALGIA; HEALTH CARE COSTS; HEALTH SERVICES; HEALTH SERVICES RESEARCH; HUMANS; KANSAS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RHEUMATIC DISEASES; SURGICAL PROCEDURES, OPERATIVE; UNITED STATES;

EID: 0030771393     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400904     Document Type: Article

References (40)

1. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, Russell IJ, Yunus MB: The work and disability status of persons with fibromyalgia. J Rheumatol (in press)
2. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, Russell IJ, Yunus MB: Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 40:1571-1579, 1997
3. Cathey MA, Wolfe F, Kleinheksel SM, Hawley DJ: Socioeconomic impact of fibrositis: a study of 81 patients with primary fibrositis. Am J Med 81:78-84, 1986
4. Ercolani M, Trombini G, Chattat R, Cervini C, Piergiacomi G, Salaffi F, Marcolongo R: Fibromyalgia syndrome: depression and abnormal illness behavior: a multicenter investigation. Psychother Psychosom 61:178-186, 1994
5. Kellner R: Psychosomatic syndromes, somatization and somato-form disorders. Psychother Psychosom 61:4-24, 1994
6. Robbins JM, Kirmayer LJ, Kapusta MA: Illness worry and disability in fibromyalgia syndrome. Int J Psychiatry Med 20:49-63, 1990
7. Kirmayer LJ, Robbins JM, Kapusta MA: Somatization and depression in fibromyalgia syndrome. Am J Psychiatry 145:950-954, 1988
8. Johnson J, Weissman MM, Klerman GL: Service utilization and social morbidity associated with depressive symptoms in the community. JAMA 267:1478-1483, 1992
9. Manning WG, Wells KB: The effects of psychological distress and psychological well-being on use of medical services. Med Care 30:541-553, 1992
10. Von Korff M, Ormel J, Katon W, Lin EHB: Disability and depression among high utilizers of health care - a longitudinal analysis. Arch Gen Psychiatry 49:91-100, 1992
11. Katon W, von Korff M, Lin E, Lipscomb P, Wagner E, Polk E: Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry 12:355-362, 1990
12. Barsky AJ, Wyshak G, Klerman GL: Medical and psychiatric determinants of outpatient medical utilization. Med Care 24:548-560, 1986
13. Hawley DJ, Wolfe F, Cathey MA, Roberts FK: Marital status in rheumatoid arthritis and other rheumatic disorders: a study of 7,293 patients. J Rheumatol 18:654-660, 1991
14. Wolfe F, Hawley DJ, Cathey MA: The assessment and prediction of functional disability in RA. J Rheumatol 18:1298-1306, 1991
15. Wolfe F, Fries JF: ARAMIS today: moving toward internationally distributed databank systems for follow-up studies. Clin Rheumatol 6:93-102, 1987
16. Fries JF, Williams CA, Ramey D, Bloch DA: The relative toxicity of disease-modifying antirheumatic drugs. Arthritis Rheum 36: 297-306, 1993
17. Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL: Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 11:151-171, 1981
18. Dinerman H, Goldenberg DL, Felson DT: A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol 13:368-373, 1986
19. Caro XJ: Immunofluorescent detection of IgG at the dermal-epidermal junction in patients with apparent primary fibrositis syndrome. Arthritis Rheum 27:1174-1179, 1984
20. Wolfe F, Hawley DJ, Cathey MA, Caro X, Russell IJ: Fibrositis: symptom frequency and criteria for diagnosis: an evaluation of 291 rheumatic disease patients and 58 normal individuals. J Rheumatol 12:1159-1163, 1985
21. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33:160-172, 1990
22. Fries JF, Spitz PW, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 23:137-145, 1980
23. Wolfe F: A brief clinical health assessment instrument: CLINHAQ (abstract). Arthritis Rheum 32 (suppl 4):S99, 1989
24. Wolfe F: Data collection and utilization: a methodology for clinical practice and clinical research. In, Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome, and Treatment. Edited by F Wolfe, T Pincus. New York, Marcel Dekker, 1994
25. Hawley DJ, Wolfe F: Depression is not more common in rheumatoid arthritis: a 10 year longitudinal study of 6,608 rheumatic disease patients. J Rheumatol 20:2025-2031, 1993
26. Meenan RF, Gertman PM, Mason JH, Dunaif R: The Arthritis Impact Measurement Scales: further investigations of a health status measure. Arthritis Rheum 25:1048-1053, 1982
27. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE: AIMS2: the content and properties of a revised and expanded Arthritis Impact Measurement Scales health status questionnaire. Arthritis Rheum 35:1-10, 1992
28. Burckhardt CS, Clark SR, Bennett RM: The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 18:728-733, 1991
29. Wolfe F, Kleinheksel SM, Spitz PW, Lubeck DP, Fries JF, Young DY, Mitchell DM, Roth SH: A multicenter study of hospitalization in rheumatoid arthritis: effect of health care system, severity, and regional difference. J Rheumatol 13:277-284, 1986
30. Lubeck DP, Spitz PW, Fries JF, Wolfe F, Mitchell DM, Roth SH: A multicenter study of annual health service utilization and costs in rheumatoid arthritis. Arthritis Rheum 29:488-493, 1986
31. Health Care Financing Agency: Medicare program; revisions to payment policies and adjustments to the relative value units under the physician fee schedule for the calendar year 1996. Federal Register CFR 42, 1996
32. American Hospital Association: American Hospitalization Hospital Statistics: 1995/1996 Edition. Chicago, American Hospital Association, 1995
33. Stata Corporation: Stata Statistical Software: Release 4.0. College Station, TX, Stata Corporation, 1995
34. Stata Corporation: Stata Statistical Software: Release 5.0. College Station, TX, Stata Corporation, 1997
35. Yelin E, Callahan LF, for the National Arthritis Data Work Group: The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 38:1351-1362, 1995
36. Singh G, Ramey D, Terry R, Wolfe F, Fries J: Cost of medical care for patients with osteoarthritis and rheumatoid arthritis: a 13 year study (abstract). Arthritis Rheum 39 (suppl 9):S71, 1996
37. Goldenberg DL, Felson DT, Dinerman H: A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 29:1371-1377, 1986
38. Yunus MB, Masi AT, Aldag JC: Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial. J Rheumatol 16:527-532, 1989
39. Russell IJ, Fletcher EM, Michalek JE, Mcbroom PC, Hester GG: Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: a double-blind, placebo-controlled study. Arthritis Rheum 34:552-560, 1991
40. Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bukerk VP, Edworthy SM, Baron M, Koehler BE, Fam AG, Bellamy N, Guimont C: Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, double-blind clinical trial. Arthritis Rheum 37:32-40, 1994